#Asembia22: Life Sciences accelerate digital engagement

Takeaways from our time at Asembia 2022 Specialty Pharmacy Summit

Asembia 2022 was high impact and memorable — our Life Sciences team returned feeling inspired and all the more motivated to deliver on our mission to transform healthcare by bringing innovative experiences to patients worldwide. The chance to meet with so many of our partners and potential clients was long overdue and rewarding.

After over 40 customer meetings with leading Life Sciences companies — one thing was made clear: the biopharmaceutical industry is eager to explore digital-first patient experiences and Truepill’s ability to offer modern, scalable digital patient solutions is a critical differentiator. Patient-centric models are top priority and there’s appetite for large-scale digital innovations, which includes investing in digital technologies and hiring talent.

A recent study of biopharma leaders revealed that 77% of respondents saw digital innovation as a competitive differentiator. 59% of those respondents felt that dedicated funding would help their organizations scale digital innovation, and 47% felt hiring the right talent would.

We saw this sentiment echoed again and again at Asembia. One representative from a top 20 biopharma company said they envisioned adding a virtual pharmacy to their core portfolio of products in the coming year, emphasizing the ability to provide patients both their medication and treatment supplies in regularly delivered packages.

Another partner from a top 10 biopharma company said their entire organization is moving from “doing digital” to “being digital” by 2025. They believe that future patient experiences will be generally self-service, with frictionless access to data and insights that accelerate decision-making. In order to achieve this, they will focus on hiring and partnering with digital-first companies, such as Truepill, with cultivation of capabilities for the future.

Despite the compelling interest, creating digital patient experiences on behalf of these companies is not without challenges — thus reiterating the need to partner with experts that can navigate the complex compliance and regulatory parameters in addition to knowing how to create industry-leading consumer, digital experiences.

We look forward to expanding our impact in the Life Sciences market and improving patient access and outcomes by deploying our telehealth, diagnostic, and pharmacy solutions.

Truepill connects telehealth, diagnostic, and pharmacy infrastructure to create innovative solutions for leading companies, enabling our partners to deliver modern, convenient, and accessible care. We aim to simplify the care journey for patients and provide frictionless access to treatments through streamlined distribution, compliant and scalable workflows, and speed-to-market.

If you’re interested in learning more about Truepill, reach out. Let’s talk about how we can transform healthcare together.